SARS-CoV-2 Antibody Test
- UID
- MFG/IVD/2021/000073_b15aab46799c3fae1b16f09c3d5d39c9_8844a4691715dc6665319425dd08d416
- Device class
- Class C
- Brand name
- CovAbScreen / CovAb
- License holder
- Diabetomics Medical (P) Ltd
- Approving authority
- CDSCO, Zonal office, Hyderabad
- Product information
- The CovAbScreenTM SARS-CoV-2 Ab Test is a lateral flow immunoassay intended for qualitative detection of total antibodies (CovAbScreen / CovAb) to SARS-CoV-2 in oral fluid specimen (CovAbScreen / CovAb)
SARS-CoV-2 Antibody Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2021/000073_b15aab46799c3fae1b16f09c3d5d39c9_8844a4691715dc6665319425dd08d416. This device is marketed under the brand name CovAbScreen / CovAb. The license holder is Diabetomics Medical (P) Ltd, and it is classified as Device Class Class C. The approving authority is CDSCO, Zonal office, Hyderabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.